Tirzepatide is an innovative new medication designed to treat type 2 diabetes. This injectable drug works by replicating two naturally occurring hormones, glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). By stimulating the production of insulin and decreasing glucagon release, tirzepatide effectively balances